* Adapthealth Corp AHCO.OQ AHCO.O is expected to show a
rise
in quarterly revenue when it reports results on May 9.
* The Plymouth Meeting Pennsylvania-based company is
expected to
report a 7.1% increase in revenue to $756.452 million from
$706.2 million a year ago, according to the mean estimate from 9
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Adapthealth Corp is
for
earnings of 8 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 10 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Adapthealth
Corp
is $22.5, above its last closing price of $11.00.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 0.25 0.28 -0.02 Missed -107
Sep. 30 2022 0.31 0.31 0.11 Missed -64.7
Jun. 30 2022 0.25 0.26 0.09 Missed -65
Mar. 31 2022 0.19 0.18 0.08 Missed -55.6
Dec. 0.32 0.34 0.17 Missed -50.8
31 2021
Sep. 30 2021 0.27 0.28 0.20 Missed -28.6
Jun. 30 2021 0.20 0.21 0.12 Missed -43.7
Mar. 31 2021 0.23 0.23 -0.04 Missed -117.1
This summary was machine generated May 5 at 18:31 GMT. All
figures in US dollars unless otherwise stated